These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30477515)

  • 21. High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy.
    Al-Mekhlafi AM; Mahdy MA; Al-Mekhlafi HM; Azazy AA; Fong MY
    Parasit Vectors; 2011 May; 4():94. PubMed ID: 21619624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
    Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
    Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.
    Shafik SH; Richards SN; Corry B; Martin RE
    PLoS Biol; 2022 May; 20(5):e3001616. PubMed ID: 35507548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: a Philippine study.
    Hatabu T; Iwagami M; Kawazu S; Taguchi N; Escueta AD; Villacorte EA; Rivera PT; Kano S
    Parasitol Int; 2009 Jun; 58(2):166-70. PubMed ID: 19567229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1.
    Babiker HA; Pringle SJ; Abdel-Muhsin A; Mackinnon M; Hunt P; Walliker D
    J Infect Dis; 2001 May; 183(10):1535-8. PubMed ID: 11319692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province].
    Guan YY; Tang LH; Hu L; Feng XP; Liu DQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):135-9. PubMed ID: 16299999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon.
    Ndam NT; Basco LK; Ngane VF; Ayouba A; Ngolle EM; Deloron P; Peeters M; Tahar R
    Malar J; 2017 Mar; 16(1):130. PubMed ID: 28347314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.
    Gresty KJ; Gray KA; Bobogare A; Taleo G; Hii J; Wini L; Cheng Q; Waters NC
    Malar J; 2014 Oct; 13():406. PubMed ID: 25318907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi.
    Mita T; Kaneko A; Lum JK; Bwijo B; Takechi M; Zungu IL; Tsukahara T; Tanabe K; Kobayakawa T; Björkman A
    Am J Trop Med Hyg; 2003 Apr; 68(4):413-5. PubMed ID: 12875289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India.
    Das MK; Lumb V; Mittra P; Singh SS; Dash AP; Sharma YD
    J Antimicrob Chemother; 2010 Jun; 65(6):1258-61. PubMed ID: 20363804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in Plasmodium falciparum chloroquine resistance genes, pfcrt and pfmdr1, in North Sulawesi, Indonesia.
    Reteng P; Vrisca V; Sukarno I; Djarkoni IH; Kalangi JA; Jacobs GE; Runtuwene LR; Eshita Y; Maeda R; Suzuki Y; Mongan AE; Warouw SM; Yamagishi J; Tuda J
    BMC Res Notes; 2017 Apr; 10(1):147. PubMed ID: 28376874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in the proportion of Plasmodium falciparum with kelch13 C580Y mutation and decline in pfcrt and pfmdr1 mutant alleles in Papua New Guinea.
    Yoshida N; Yamauchi M; Morikawa R; Hombhanje F; Mita T
    Malar J; 2021 Oct; 20(1):410. PubMed ID: 34666779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paleoparasite populations from archived sera: insights into chloroquine drug resistance in Papua New Guinea.
    Chan CW; Garruto RM; Lum JK
    J Infect Dis; 2006 Oct; 194(7):1023-4; author reply 1024-5. PubMed ID: 16960794
    [No Abstract]   [Full Text] [Related]  

  • 37. Low rates of Plasmodium falciparum Pfcrt K76T mutation in three sentinel sites of malaria monitoring in Côte d'Ivoire.
    Konaté A; Gnagne PA; Bédia-Tanoh VA; Amiah-Droh M; Tano DK; Ignace Eby Menan H; Yavo W
    Acta Parasitol; 2018 Dec; 63(4):795-801. PubMed ID: 30367773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites.
    Laufer MK; Takala-Harrison S; Dzinjalamala FK; Stine OC; Taylor TE; Plowe CV
    J Infect Dis; 2010 Sep; 202(5):801-8. PubMed ID: 20662717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.
    Mang'era CM; Mbai FN; Omedo IA; Mireji PO; Omar SA
    Acta Trop; 2012 Sep; 123(3):202-7. PubMed ID: 22641431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.